Carlyle, MBK among bidders for S.Korea pharma firm CJ HealthCare - Korea Economic Daily

Kolmar Korea

19/12/2017 06:15

SEOUL, Dec 19 (Reuters) - Private equity firms Carlyle 
 CG.O  and MBK Partners are among the bidders for South Korean 
pharmaceutical company CJ HealthCare Corp in a deal estimated to 
be worth about 1 trillion won ($919.62 million), Korea Economic 
Daily reported on Tuesday.  
    Parties that have entered non-binding bids include Bain 
Capital, TPG, CVC Capital and South Korean cosmetics 
manufacturer Korea Kolmar Co Ltd  161890.KS , the paper reported 
citing an unnamed investment banking source.  
    CJ Cheiljedang  097950.KS , South Korea's No.1 food company, 
is looking to sell its 100 percent stake in CJ HealthCare, a 
Cheiljedang spokesman said. He declined further comment.  
    Morgan Stanley is advising the sale.  
    Carlyle and MBK Partners declined comment. Morgan Stanley 
and CVC did not have an immediate comment. Bain Capital, TPG and 
Korea Kolmar could not be immediately reached.  
 
($1 = 1,087.4000 won) 
 
 (Reporting by Joyce Lee; Editing by Stephen Coates) 
 ((jungyoon.lee@thomsonreuters.com; +82 2 3704 5609; Reuters 
Messaging: jungyoon.lee.thomsonreuters.com@reuters.net)) 
 
Keywords: CJ HEALTHCARE M&A/